ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,226,512 | +23.1% | 118,884 | +39.4% | 0.01% | 0.0% |
| Q2 2023 | $2,620,769 | -37.4% | 85,256 | -26.6% | 0.01% | -28.6% |
| Q1 2023 | $4,187,731 | -20.5% | 116,229 | -12.8% | 0.01% | -30.0% |
| Q4 2022 | $5,268,846 | +6.0% | 133,321 | +7.8% | 0.01% | 0.0% |
| Q3 2022 | $4,969,000 | +105.9% | 123,673 | +115.5% | 0.01% | +400.0% |
| Q2 2022 | $2,413,000 | +164.9% | 57,382 | +145.2% | 0.00% | +100.0% |
| Q1 2022 | $911,000 | -18.1% | 23,405 | -16.2% | 0.00% | 0.0% |
| Q4 2021 | $1,113,000 | +82.5% | 27,917 | +65.3% | 0.00% | – |
| Q3 2021 | $610,000 | +45.6% | 16,885 | +65.2% | 0.00% | – |
| Q2 2021 | $419,000 | +94.0% | 10,223 | +106.0% | 0.00% | – |
| Q1 2021 | $216,000 | -12.9% | 4,963 | 0.0% | 0.00% | – |
| Q4 2020 | $248,000 | – | 4,963 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |